Prof. Akihiro "Sam" Shimosaka serves as the Chief Executive Officer and President of BioOne Corporation and Beijing BioOne Medical Technology Co., Ltd. Prior to this he also served as Vice President of Licensing Department, Pharmaceutical Division of Kirin Brewery Company and as Advisor to Medinet Co. Ltd. Additionally, dr. Shimosaka has extensive domestic and international experience in early and later stage biotechnology companies in research and development, product development and regulatory issues. Dr. Shimosaka also held the following positions: Member of the Scientific & Clinical Advisory Board of Vaccinex, Inc. and Member of Scientific Advisory Board at IR Biosciences Holdings Inc. Dr. Shimosaka is a Honorary Professor at Institute of Hematology, Peking Union Medical College, Chinese Academy of Medical Sciences, Peking University School of Oncology and visiting professor at Tokyo Institute of Technology.
Prof. Akihiro Shimosaka PhD
BioOne Corporation and Beijing BioOne Medical Technology Co., Ltd.